Genu Recurvatum Market Report 2026

Genu Recurvatum Market Overview

• Genu Recurvatum market size has reached to $8.04 billion in 2025 • Expected to grow to $11.49 billion in 2030 at a compound annual growth rate (CAGR) of 7.5% • Growth Driver: Growing Preference For Minimally Invasive Surgeries Fueling The Growth Of The Market Due To Faster Recovery And Reduced Surgical Risks • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Genu Recurvatum Market?

Genu recurvatum is a medical condition characterized by hyperextension of the knee joint, resulting in the knee bending backward beyond its normal range of motion. The main treatments for genu recurvatum are strengthening the quadriceps muscles, wearing a brace to prevent hyperextension, or proceeding with a proximal tibial osteotomy, which increases the slope of the tibia to decrease or eliminate the condition. The main genu recurvatum types are external rotatory deformity (ERD), internal rotatory deformity (IRD), and non-rotatory deformity (NRD). External rotatory deformity (ERD) refers to a type of rotational deformity that occurs when the foot or leg bone is twisted outward. The various diagnosis is magnetic resonance imaging (MRI), x-rays, and others, which can be treated with physical therapy, orthoses, bracing, and surgery. The end users are hospitals, clinics, and others.

What Is The Genu Recurvatum Market Growth Forecast?

The genu recurvatum market size is expected to see strong growth in the next few years. It will grow to $11.49 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to advances in orthopedic devices, personalized bracing solutions, growth of physiotherapy services, aging population, improved diagnostic imaging. Major trends in the forecast period include increased adoption of non-surgical treatment approaches, growing use of custom orthotic bracing, rising demand for physical therapy-based management, expansion of minimally invasive surgical techniques, increased focus on early diagnosis and intervention.

Global Genu Recurvatum Market Segmentation

1) By Type: External Rotatory Deformity (ERD), Internal Rotatory Deformity (IRD), Non-Rotatory Deformity (NRD) 2) By Diagnosis: Magnetic Resonance Imaging (MRI), X-Rays, Other Diagnosis 3) By Treatment: Physical Therapy, Orthoses, Bracing, Surgery 4) By End-Users: Hospital, Clinics, Other End-Users Subsegments: 1) By External Rotatory Deformity (ERD): Mild ERD, Moderate ERD, Severe ERD 2) By Internal Rotatory Deformity (IRD): Mild IRD, Moderate IRD, Severe IRD 3) By Non-Rotatory Deformity (NRD): Fixed NRD, Flexible NRD

What Are The Drivers Of The Genu Recurvatum Market?

The growing preference for minimally invasive surgeries is expected to propel the growth of the genu recurvatum market going forward. Minimally invasive surgeries refer to medical procedures that involve small incisions or no incisions at all, using advanced tools such as cameras and specialized instruments to reduce tissue damage, shorten recovery time, and minimize scarring compared to traditional open surgery. The growing preference for minimally invasive surgeries is attributed to their ability to offer reduced recovery times, lower risk of infection, less scarring, and shorter hospital stays. Genu recurvatum supports minimally invasive surgeries by improving knee alignment and stability, which helps surgeons operate with reduced tissue disruption and greater precision. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, reported that minimally invasive procedures experienced a 7 percent growth in 2023, exceeding the growth rate of surgical procedures by 2 percent. Therefore, growing preference for minimally invasive surgeries is driving the growth of the genu recurvatum industry. The increasing prevalence of orthopedic disorders is expected to propel the growth of the genu recurvatum market going forward. Orthopedic disorders refer to conditions that affect the musculoskeletal system, including the bones, joints, muscles, tendons, ligaments, and cartilage. Genu recurvatum causes knee pain and leads to knee osteoarthritis and other orthopedic disorders. The increasing cases of orthopedic conditions will demand treatment, which will support the market's growth. For instance, in June 2024, according to the Australian Institute of Health and Welfare (AIHW), an Australia-based government statistical and research agency, reported that osteoarthritis accounted for 2.5% of the total disease burden and 20% of the total burden of disease due to musculoskeletal conditions in 2023. Therefore, the increasing prevalence of orthopedic disorders is driving the growth of the genu recurvatum industry.

Key Players In The Global Genu Recurvatum Market

Major companies operating in the genu recurvatum market are Johnson & Johnson MedTech, Stryker Corporation, DePuy Synthes Inc., Zimmer Inc., Smith & Nephew plc, Arthrex, DJO Global Inc., Össur hf, AliMed Inc., Thuasne Ltd., OrthoPro Inc., Performance Health, Trulife Group Limited, Breg Inc., Allard USA, Capstone Orthopedic Inc., BraceAbility, Globus Medical, Medtronic plc, ConMed Corporation, Bioventus, Medacta International, Ottobock SE & Co. KGaA, Exactech Inc.

What Are Latest Mergers And Acquisitions In The Genu Recurvatum Market?

In April 2023, Nuvasive, Inc., a US-based medical device company, merged with Globus Medical Inc. for an undisclosed sum. This merger helped unite two respected technological firms in the Musculoskeletal sector and better serve doctors and hospital partners by advancing innovation, expanding global medical and commercial reach, and supporting more patients. Globus Medical Inc. is a US-based company that develops, manufactures, and distributes musculoskeletal device solutions and offers revision knee replacement.

Regional Outlook

North America was the largest region in the genu recurvatum market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genu Recurvatum Market?

The genu recurvatum market includes of revenues earned by entities by providing services such as physiotherapy and strengthening of calf muscles. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Genu Recurvatum Market Report 2026?

The genu recurvatum market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the genu recurvatum industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.